A hospital-based matched case-control study to identify risk factors for clinical infection with OXA-48-producing Klebsiella pneumoniae in rectal carriers

Epidemiology and Infection

Volumn 145, Issue 12, 2017, Pages 2626-2630

  Madueno A ^a   Gonzalez Garcia, J ^a   Aguirre Jaime, A ^b   Lecuona, M ^a,c  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^c UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

Antibiotic resistance; hospital acquired (nosocomial) infections; Klebsiella

Indexed keywords

BETA LACTAMASE CTX M15; BETA LACTAMASE OXA 48; CARBAPENEMASE; HYDROLASE; UNCLASSIFIED DRUG; BETA LACTAMASE; OXACILLINASE;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM CARRIER; BACTERIUM CULTURE; BACTERIUM ISOLATE; CARBAPENEMASE PRODUCING KLEBSIELLA PNEUMONIAE INFECTION; CASE CONTROL STUDY; CONTROLLED STUDY; ENZYME SYNTHESIS; FEMALE; HIGH RISK PATIENT; HOSPITAL BASED CASE CONTROL STUDY; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFECTION CONTROL; INFECTION RISK; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OBSERVATIONAL STUDY; OXA 48 PRODUCING KLEBSIELLA PNEUMONIAE; PATIENT TRANSPORT; RECTUM; RETROSPECTIVE STUDY; RISK FACTOR; GENETICS; KLEBSIELLA INFECTIONS; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PHYSIOLOGY; SPAIN; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BETA-LACTAMASES; CASE-CONTROL STUDIES; FEMALE; HOSPITALIZATION; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; RECTUM; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN;

EID: 85024384998     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S095026881700142X     Document Type: Article

References (15)

1. World Health Organization (WHO). Antimicrobial Resistance: Global Report on Surveillance, 2014. Geneva: WHO, 2014, pp. 1-256.
2. Paño Pardo JR, et al. Infections caused by carbapenemaseproducing Enterobacteriaceae: risk factors, clinical features and prognosis. Enfermedades Infecciosas y Microbiología Clínica 2014; 32(Suppl. 4): 41-48.
3. Tzouvelekis LS, et al. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clinical Microbiology Reviews 2012; 25: 682-707.
4. ComunidaddeMadrid. Plan de prevención y control frente a la infeccion por Enterobacterias Productoras de Carbapenemasas (EPC) en la Comunidad de Madrid. 2013 (http://www.madrid.org/cs/Satellite?blobcol=urldata&blobheader=application%2Fpdf&blobheadername1= Content-disposition&blobheadername2=cadena&blobheadervalue1= filename%3DPLAN+PREVENCION+Y+ CONTROL+EPC+CM-v1-sept+2013.pdf&blobheadervalue2= language%3Des%26site%3DPortalSalud&blobkey= id&blobtable=MungoBlobs&blobwhere=1352838664 739&ssbinary=true). Accessed 27 July 2016.
5. Tacconelli E, et al. European Society of Clinical Microbiology. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clinical Microbiology and Infection 2014; 20(Suppl. 1): 1-55.
6. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Fourth Informational Supplement M100-S24. Wayne, PA, USA: CLSI, 2014.
7. EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance (http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST-files/Resistance-mechanisms/EUCAST-detection-of-resistance-mechanisms-v1.0- 20131211.pdf). Version 1.0, December 2013. Accessed 27 July 2016.
8. Definitions S. CDC/NHSN Surveillance definitions for specific types of infections. 2016 (http://www.cdc.gov/nhsn/pdfs/pscmanual/17pscnosinfdef-current.pdf). Accessed September 2016.
9. BorerA, et al.Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenemresistant K. pneumoniae. American Journal of Infection Control 2012; 40: 421-425.
10. Correa L, et al. A hospital-based matched case-control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infection. BMC Infectious Diseases 2013; 13: 80.
11. Gregory CJ, et al. Outbreak of carbapenem-resistant Klebsiella pneumoniae in Puerto Rico associated with a novel carbapenemase variant. Infection Control and Hospital Epidemiology 2010; 31: 476-484.
12. Eveillard M, et al. Association between hospital-acquired infections and patients' transfers. Infection Control and Hospital Epidemiology 2001; 22: 693-696.
13. Vergara-López S, et al. Lessons from an outbreak of metallo-?-lactamase-producing Klebsiella oxytoca in an intensive care unit: the importance of time at risk and combination therapy. Journal of Hospital Infection 2015; 89: 123-131.
14. French CE, et al. Control of carbapenemase-producing Enterobacteriaceae outbreaks in acute settings: an evidence review. Journal of Hospital Infection 2017; 95: 3-45.
15. Paño-Pardo JR, et al. Infections caused by OXA-48-producing Klebsiella pneumoniae in a tertiary hospital in Spain in the setting of a prolonged, hospitalwide outbreak. Journal of Antimicrobial Chemotherapy 2013; 68: 89-96.